Evolv Technologies Holdings, Inc.

Listed Company

EVLVCIK 0001805385NasdaqNon-AcceleratedComputer Peripheral Equipment, NecFY ends Dec 31

Period

FY 2025

Revenue

$145.91M

Net Income

$-33.10M

Total Assets

$304.41M

Equity

$119.42M

Shares Out

179.35M

Op. Cash Flow

$18.70M

Business

Evolv Technologies Holdings, Inc. is a security technology company that develops and delivers AI-powered screening systems to enhance weapons detection and improve visitor experiences at venues and facilities. It offers integrated hardware, AI software, and cloud services delivered primarily as multi-year Security-as-a-Service subscriptions, including Evolv Express for people screening, Evolv eXpedite for autonomous bag scanning, and the Evolv Insights analytics application. Its business encompasses product development, analytics, subscription services, and support backed by ongoing R&D. Evolv serves education, healthcare, sports, live entertainment, industrial workplaces, and other venue operators globally through direct sales and a network of value-added resellers.

Summary from filing dated 2025-04-28

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenue	146	104	80	53	23
Total cost of revenue	71	44	48	51	19
Gross profit	75	59	32	1	4
Research and development	21	23	24	19	11
Sales and marketing	46	61	55	47	26
General and administrative	55	57	42	38	20
Restructuring costs	3	860,000	—	—	—
Loss on impairment of property and equipment	0	200,000	300,000	1	2
Total operating expenses	124	142	122	104	59
Loss from operations	−48	−82	−90	−103	−55
Interest expense	−2	0	−654,000	−712,000	—
Interest income	2	3	6	3	0
Other income (expense), net	99,000	−83,000	−84,000	−64,000	−617,000
Change in fair value of contingent earn-out liability	12	16	−15	7	47
Change in fair value of contingently issuable/returnable common stock liability/asset	3	3	—	—	—
Change in fair value of public warrant liability	435,000	7	−5	5	13
Total other income, net	15	28	−18	16	44
Loss before income taxes	−33	−54	−108	−87	—
Provision for income taxes	62,000	0	−51,000	0	—
Net loss	−33	−54	−108	−87	−11
Weighted average common shares outstanding - basic (in shares)	168	157	149	144	72
Weighted average common shares outstanding - diluted (in shares)	168	157	149	144	72
Net loss per share - basic (in dollars per share)	−0.2	−0.34	−0.72	−0.6	−0.15
Net loss per share - diluted (in dollars per share)	−0.2	−0.34	−0.72	−0.6	−0.15
Cumulative translation adjustment	−109,000	21,000	−43,000	−10,000	0
Total other comprehensive (loss) income	−109,000	21,000	−43,000	−10,000	0
Total comprehensive loss	−33	−54	−108	−87	−11

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2024 2024-06-30	FY 2024 2024-03-31	FY 2023 2023-12-31
Cash and cash equivalents	49	37	36	45	67
Marketable securities	20	15	—	—	—
Accounts receivable, net of allowance for expected credit losses of $600 and $734 as of December 31, 2025 and December 31, 2024, respectively	31	28	35	20	22
Inventory	9	17	19	12	10
Current portion of contract assets	900,000	800,000	2	659,000	1
Current portion of commission asset	6	5	5	5	4
Prepaid expenses and other current assets	35	18	20	21	17
Total current assets	151	121	137	138	173
Contract assets, noncurrent	15,000	700,000	608,000	1	1
Commission asset, noncurrent	8	8	7	7	7
Property and equipment, net	128	124	121	130	113
Operating lease right-of-use assets	12	14	2	3	1
Other assets	5	735,000	865,000	999,000	1
Total assets	304	268	269	280	297
Accounts payable	10	10	6	16	17
Accrued expenses and other current liabilities	35	20	16	14	16
Current portion of deferred revenue	75	65	57	45	47
Current portion of operating lease liabilities	3	2	2	2	1
Total current liabilities	123	97	80	76	81
Deferred revenue, noncurrent	17	20	25	26	25
Long-term debt	29	0	—	—	0
Operating lease liabilities, noncurrent	11	12	566,000	980,000	0
Contingent earn-out liability, noncurrent	374,000	13	6	22	29
Contingently issuable common stock liability, noncurrent	2	4	2	6	7
Public warrant liability, noncurrent	4	4	—	—	—
Total liabilities	185	150	118	140	153
Commitments and contingencies (Note 19)	—	—	—	—	—
Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2025 and December 31, 2024; no shares issued and outstanding at December 31, 2025 and December 31, 2024	0	0	0	0	0
Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2025 and December 31, 2024, 175,399,488 and 159,602,069 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	18,000	16,000	16,000	16,000	15,000
Additional paid-in capital	507	472	460	452	445
Accumulated other comprehensive loss	−141,000	−32,000	−42,000	−50,000	−53,000
Accumulated deficit	−388	−355	−309	−312	−301
Stockholders equity	119	118	151	140	144
Total liabilities and stockholders equity	304	268	269	280	297

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	24	17	10	5	3
Write-off of inventory and change in inventory reserve	3	3	1	2	2
Loss on impairment of intangible asset	0	983,000	0	0	—
Loss on disposal of property and equipment	4	0	—	0	617,000
Stock-based compensation	21	25	24	23	10
Non-cash interest expense	482,000	0	22,000	55,000	5
(Accretion) amortization of (discount) premium on marketable securities, net of change in accrued interest	−126,000	447,000	−575,000	0	—
Non-cash lease expense	2	1	478,000	811,000	0
Change in allowance for expected credit losses	−134,000	152,000	382,000	150,000	—
Accounts receivable	−2	−7	5	−20	−5
Inventory	9	−8	960,000	−11	−3
Commission assets	−933,000	−1	−3	−3	−3
Contract assets	563,000	905,000	1	1	−5
Other assets	750,000	467,000	633,000	−419,000	32,000
Prepaid expenses and other current assets	−23	−964,000	−2	−3	−9
Accounts payable	4	192,000	−6	8	765,000
Deferred revenue	7	13	39	23	5
Accrued expenses and other current liabilities	19	5	4	1	2
Operating lease liability	−886,000	−1	−615,000	−946,000	0
Net cash provided by (used in) operating activities	19	−31	−10	−75	−57
Development of internal-use software	−6	−6	−4	−3	−1
Purchases of property and equipment	−31	−31	−69	−21	−17
Purchases of marketable securities	−39	−29	−90	0	—
Proceeds from maturities of marketable securities	35	65	39	0	—
Net cash used in investing activities	−42	−1	−123	−24	−18
Proceeds from exercise of stock options	9	2	668,000	827,000	915,000
Proceeds from long-term debt	26	0	2	30	32
Net cash provided by financing activities	35	2	−30	21	378
Effect of exchange rate changes on cash and cash equivalents	−109,000	21,000	−43,000	−10,000	0
Net increase (decrease) in cash and cash equivalents	12	−30	−163	−78	303
Cash paid for interest	1	0	710,000	581,000	850,000
Transfer of property and equipment to inventory	5	1	218,000	454,000	13
Capital expenditures incurred but not yet paid	4	5	13	8	3
Capitalization of stock compensation	1	941,000	516,000	205,000	53,000
Operating lease liabilities arising from obtaining right-of-use assets	0	14	0	0	—
Conversion of contingently issuable common stock	4	0	—	0	76

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro